PB2708: SYMPTOM BURDEN AND ITS IMPACT ON DAILY LIFE IN PATIENTS WITH IDIOPATHIC MULTICENTRIC CASTLEMAN’S DISEASE (IMCD): AN EXPLORATORY ANALYSIS OF THE SURVEY’S INTERNAL CONSTRUCT VALIDITY
Matt Franklin,
Francis Shupo,
Emily Jones,
Nicola Mason,
Grace Wayi-Wayi,
Karan Kanhai,
Natasa Zibelnick,
Mileva Repasky,
Kelly Makarounas-Kirchmann,
Sudipto Mukherjee,
John Brazier
Affiliations
Matt Franklin
1 School of Health and Related Research, sheffield, United Kingdom
Francis Shupo
2 EUSA Pharma UK Ltd, Hemel Hempstead, United Kingdom
Emily Jones
3 Lumanity, London, United Kingdom
Nicola Mason
3 Lumanity, London, United Kingdom
Grace Wayi-Wayi
2 EUSA Pharma UK Ltd, Hemel Hempstead, United Kingdom
Karan Kanhai
2 EUSA Pharma UK Ltd, Hemel Hempstead, United Kingdom
Natasa Zibelnick
2 EUSA Pharma UK Ltd, Hemel Hempstead, United Kingdom
Mileva Repasky
4 Castleman disease collaborative network, Paso Robles, United States
Kelly Makarounas-Kirchmann
5 Monash University, School of Public Health, Melbourne, Australia
Sudipto Mukherjee
6 Cleveland Clinic Main Campus, Cleveland, United States
John Brazier
1 School of Health and Related Research, sheffield, United Kingdom
